Express Scripts Holdings Co.

Registered Principal Details

Business Or Interest:
Pharmaceutical Benefits Management

Lobbying Interests:
All matters relating to pharmaceuticals, pharmacy benefits management and prescription drug programs.

CEO Name:
Tim Wentworth
VP-Gov't Affairs

Contact
DMD
David M. Dederichs
300 New Jersey Ave NW, #600
Washington, DC 20001
(952) 837-5177
DMDederichs@express-scripts.com
http://www.express-scripts.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Jason E Johns Exclusive Duties N/A Authorized On 1/31/2017 Withdrawn On 3/27/2018
Tangela Feemster Exclusive Duties N/A Authorized On 5/3/2017 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 359
Assembly Bill 359
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)

Bill Text and History

For
Notification Date
6/2/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 263
Senate Bill 263
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)

Bill Text and History

For
Notification Date
6/2/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Maters pertaining to the Controlled Substances Board
Development, drafting or introduction of a proposal relating to
Maters pertaining to the Controlled Substances Board

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Maximum Allowable Cost (MAC) for pharmaceuticals
Development, drafting or introduction of a proposal relating to
Matters pertaining to Maximum Allowable Cost (MAC) for pharmaceuticals

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Any Willing Provider (AWP) laws
Development, drafting or introduction of a proposal relating to
Matters pertaining to Any Willing Provider (AWP) laws

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Biosimilars
Development, drafting or introduction of a proposal relating to
Matters pertaining to Biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Healthcare Reform within and without PPACA
Development, drafting or introduction of a proposal relating to
Matters pertaining to Healthcare Reform within and without PPACA

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters relating to Pharmacy Services Administrative Organizations
Development, drafting or introduction of a proposal relating to
Matters relating to Pharmacy Services Administrative Organizations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$27,000.00
2017
July - December
$27,000.00
2018
January - June
$0.00
2018
July - December
$0.00
Total $54,000.00
Total Hours Communicating 2017
January - June
2.00
2017
July - December
10.75
2018
January - June
0.00
2018
July - December
0.00
Total 12.75
Total Hours Other 2017
January - June
70.75
2017
July - December
65.00
2018
January - June
0.00
2018
July - December
0.00
Total 135.75

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
5 %
2017
July - December
2018
January - June
2018
July - December
Total 3 %
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
5 %
2017
July - December
2018
January - June
2018
July - December
Total 3 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10 %
2018
January - June
2018
July - December
Total 5 %
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
25 %
2018
January - June
2018
July - December
Total 13 %

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
5 %
2018
January - June
2018
July - December
Total 3 %

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
90 %
2017
July - December
60 %
2018
January - June
2018
July - December
100 %
Total 75 %

Filed Statements of Lobbying Activity and Expenditures